Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal

<strong>Background</strong> The 2014 West African outbreak of Ebola virus disease highlighted the urgent need to develop an effective Ebola vaccine. <strong>Methods</strong> We undertook two Phase I studies assessing safety and immunogenicity of the viral vector MVA-EBO-Z, m...

Full description

Bibliographic Details
Main Authors:	Venkatraman, N, Ndiaye, B, Bowyer, G, Wade, D, Sridhar, S, Wright, D, Powlson, J, Ndiaye, I, Dièye, S, Thompson, C, Bakhoum, M, Morter, R, Capone, S, Del Sorbo, M, Jamieson, S, Rampling, T, Dattoo, M, Roberts, R, Poulton, I, Griffiths, O, Ballou, W, Roman, F, Lewis, DJM, Lawrie, A, Imoukhuede, E, Gilbert, S, Dieye, TN, Ewer, KJ, Hill, A, Mboup, S
Format:	Journal article
Published:	Oxford University Press 2018

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal

Similar Items